An evaluation of inhaled antibiotic liposome versus antibiotic nanoplex in controlling infection in bronchiectasis
Inhaled antibiotic nanoparticles have emerged as an effective strategy to control infection in bronchiectasis lung owed to their mucus-penetrating ability. Using ciprofloxacin (CIP) as the model antibiotic, we evaluated dry powder inhaler (DPI) formulations of two classes of antibiotic nanoparticles...
Main Authors: | Tran, The-Thien, Yu, Hong, Vidaillac, Celine, Lim, Albert Y. H., Abisheganaden, John A., Chotirmall, Sanjay Haresh, Hadinoto, Kunn |
---|---|
Other Authors: | School of Chemical and Biomedical Engineering |
Format: | Journal Article |
Language: | English |
Published: |
2020
|
Subjects: | |
Online Access: | https://hdl.handle.net/10356/144358 |
Similar Items
-
A new therapeutic avenue for bronchiectasis : dry powder inhaler of ciprofloxacin nanoplex exhibits superior ex vivo mucus permeability and antibacterial efficacy to its native ciprofloxacin counterpart
by: Tran, The-Thien, et al.
Published: (2020) -
Evaluation of subconjunctival liposomal steroids for the treatment of experimental uveitis
by: Wong, Chee Wai, et al.
Published: (2018) -
Characterization of liposome-encapsulated tylosin, in vitro Cytotoxicity and its antibacterial activitiy against Corynebacterium pseudotuberculosis isolated from goats
by: Saddiqi, Mohammad Ehsan
Published: (2022) -
A concise review of gold nanoparticles-based photo-responsive liposomes for controlled drug delivery
by: Mathiyazhakan, Malathi, et al.
Published: (2018) -
Clinical Aspergillus signatures in COPD and bronchiectasis
by: Tiew, Pei Yee, et al.
Published: (2022)